Orchestra BioMed (OBIO) Misses Q1 EPS by 49c

Orchestra BioMed (NASDAQ: OBIO) reported Q1 EPS of ($0.49). Revenue for the quarter came in at $900 thousand.

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AIG (AIG) on Watch Following Unconfirmed M&A Chatter
• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ